Target intelligence / Profile preview

Calcium deposition in necrotic myocardium (None commonly used)

Target
None commonly used
Molecular classification
Other (not an enzyme, transporter, receptor, ion channel, or gene product)
01

Overview

Calcium deposition in necrotic myocardium refers to the pathologic accumulation of calcium salts within areas of dead or dying cardiac tissue, usually following injury or disruption of calcium-phosphorus homeostasis. This can occur as dystrophic calcification (in injured/necrotic myocardium with normal systemic calcium levels) or metastatic calcification (in normal myocardium with systemic disturbances, such as chronic renal failure or hyperparathyroidism)[1][2][4]. The process is most commonly seen in the setting of myocardial infarction, severe infection/sepsis, or metabolic disturbances, and may be visualized radiologically on cardiac imaging[1][2][3]. Calcified areas may contribute to mechanical dysfunction of the heart (stiffness, arrhythmias) and often persist after resolution of the acute insult, though partial or complete resolution may be possible in rare circumstances[3]. There is currently no definitive therapy for myocardial calcification except for cardiac transplantation in extreme cases[2][3][4].

Other names
Myocardial calcificationDystrophic myocardial calcificationMetastatic myocardial calcification
02

Mechanism of action

Not applicable; no drugs target this "molecule/receptor" directly.

03

Biological functions

Pathological marker of cell death/necrosisAssociated with tissue remodeling after injury to myocardium
04

Disease associations

Cardiovascular disease (seen after myocardial infarction, sepsis, chronic kidney disease, acute pancreatitis, myocarditis)Other (can be a consequence of systemic diseases that disturb calcium-phosphate homeostasis, e.g. chronic renal failure, hyperparathyroidism, malignancy)
05

Safety considerations

May contribute to ventricular arrhythmias, restrictive physiology, increased myocardial stiffness, systolic dysfunction, sudden cardiac deathPersistence of calcifications after acute events; generally irreversible except in rare cases
06

Interacting drugs

There are no drugs that directly target calcium deposition in necrotic myocardium. Management is supportive; cardiac transplantation has been considered in severe cases
07

Biomarkers

Imaging markers (CT, MRI, echocardiography showing cardiac calcification; may be useful for diagnostic purposes)Biomarkers of underlying processes (serum calcium, phosphate, parathyroid hormone levels)

Beyond the preview

Go deeper on Calcium deposition in necrotic myocardium (None commonly used).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Calcium deposition in necrotic myocardium (None commonly used).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call